Sarah Doffman

870 total citations · 1 hit paper
15 papers, 598 citations indexed

About

Sarah Doffman is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah Doffman has authored 15 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah Doffman's work include Pediatric health and respiratory diseases (4 papers), Antifungal resistance and susceptibility (4 papers) and IL-33, ST2, and ILC Pathways (4 papers). Sarah Doffman is often cited by papers focused on Pediatric health and respiratory diseases (4 papers), Antifungal resistance and susceptibility (4 papers) and IL-33, ST2, and ILC Pathways (4 papers). Sarah Doffman collaborates with scholars based in United Kingdom, United States and Singapore. Sarah Doffman's co-authors include Athol U. Wells, Gareth Reynold Davies, Robert Wilson, Samir Agrawal, Mark Wilks, Doris M. Rassl, David M. Hansell, Thomas V. Colby, A.G. Nicholson and Paul Craig and has published in prestigious journals such as Clinical Infectious Diseases, European Respiratory Journal and Thorax.

In The Last Decade

Sarah Doffman

14 papers receiving 585 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4

2025 19 citations Dave Singh, Sarah Doffman et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Doffman United Kingdom	10	281	225	204	79	54	15	598
Keitaro Nakamoto Japan	13	202 0.7×	182 0.8×	113 0.6×	65 0.8×	63 1.2×	63	557
Soheila Khalilzadeh Iran	13	170 0.6×	193 0.9×	197 1.0×	117 1.5×	26 0.5×	73	542
Sevin Kırdar Türkiye	11	156 0.6×	146 0.6×	126 0.6×	39 0.5×	43 0.8×	48	477
Cathy Kessinger United States	15	308 1.1×	620 2.8×	321 1.6×	62 0.8×	111 2.1×	31	868
Toyomitsu Sawai Japan	12	115 0.4×	206 0.9×	214 1.0×	54 0.7×	111 2.1×	43	485
Lydie Lemonnier France	15	668 2.4×	446 2.0×	267 1.3×	129 1.6×	57 1.1×	34	1.1k
Changzhou Shao China	11	84 0.3×	133 0.6×	139 0.7×	31 0.4×	66 1.2×	34	339
Kimberly H. Palkowetz United States	11	199 0.7×	259 1.2×	71 0.3×	55 0.7×	38 0.7×	20	704
Angelo Cazzadori Italy	15	145 0.5×	352 1.6×	337 1.7×	129 1.6×	36 0.7×	43	753
N. Kristine Leos United States	11	79 0.3×	189 0.8×	89 0.4×	50 0.6×	41 0.8×	18	473

Countries citing papers authored by Sarah Doffman

Since Specialization

Citations

This map shows the geographic impact of Sarah Doffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Doffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Doffman more than expected).

Fields of papers citing papers by Sarah Doffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Doffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Doffman. The network helps show where Sarah Doffman may publish in the future.

Co-authorship network of co-authors of Sarah Doffman

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Doffman. A scholar is included among the top collaborators of Sarah Doffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Doffman. Sarah Doffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Singh, Dave, Sarah Doffman, Ulla Seppälä, et al.. (2025). A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4. European Respiratory Journal. 66(1). 2402231–2402231. 19 indexed citations breakdown →

Singh, Neeraj Pal, Sarah Doffman, Ulla Seppälä, et al.. (2024). S92 FRONTIER-4: a phase 2a study to investigate tozorakimab (anti-IL-33 mAb) in COPD. A68.1–A68. 1 indexed citations

Doffman, Sarah, Ulla Seppälä, Rachel Moate, et al.. (2024). S91 Tozorakimab (anti-IL-33 mAb) reduces mucus plugging in COPD: an imaging sub-study in the FRONTIER-4 phase 2a COPD trial. A67–A68. 1 indexed citations

Asimus, Sara, Jason P. Cooper, Davinder Dosanjh, et al.. (2024). Pharmacokinetics of AZD8630/AMG 104 inhaled anti-TSLP in healthy adults and asthma patients. PA3558–PA3558. 1 indexed citations

Pandya, Hitesh, Sarah Doffman, Lars H. Nordenmark, et al.. (2024). Late Breaking Abstract - FRONTIER-4: a phase 2a study to investigate tozorakimab (anti-IL-33 mAb) in COPD. OA1964–OA1964. 1 indexed citations

Scourfield, Andrew, Sarah Doffman, & Robert F. Miller. (2014). Chronic obstructive pulmonary disease in patients with HIV: an emerging problem. British Journal of Hospital Medicine. 75(12). 678–684. 7 indexed citations

Doffman, Sarah & Robert F. Miller. (2013). Interstitial Lung Disease in HIV. Clinics in Chest Medicine. 34(2). 293–306. 18 indexed citations

Tsitsikas, Dimitris A., Shamzah Araf, Gemma Johnson, et al.. (2012). Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Medical Mycology. 50(5). 538–542. 34 indexed citations

Ashman, Neil, Peter Davies, Sarah Doffman, et al.. (2010). Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 65(6). 559–570. 85 indexed citations

10.

Lambourne, Jonathan, Dan Agranoff, Raoul Herbrecht, et al.. (2009). Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients. Clinical Infectious Diseases. 49(10). 1486–1491. 61 indexed citations

11.

Davies, Gareth Reynold, et al.. (2006). The effect ofPseudomonas aeruginosaon pulmonary function in patients with bronchiectasis. European Respiratory Journal. 28(5). 974–979. 140 indexed citations

12.

Doffman, Sarah, et al.. (2006). Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR. Journal of Medical Microbiology. 55(9). 1187–1191. 73 indexed citations

13.

Doffman, Sarah, Samir Agrawal, & Jeremy Brown. (2005). Invasive pulmonary aspergillosis. Expert Review of Anti-infective Therapy. 3(4). 613–627. 14 indexed citations

14.

Craig, Paul, Athol U. Wells, Sarah Doffman, et al.. (2004). Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology. 45(3). 275–282. 98 indexed citations

15.

Davison, Aidan, et al.. (2004). Telemedicine for multidisciplinary lung cancer meetings. Journal of Telemedicine and Telecare. 10(3). 140–143. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact